Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05224271 · ClinicalTrials.gov registry record
Evaluating Patient Reported Outcomes in Radiation Therapy, the PRO-RT Study
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 18
- Enrollment target
NCT05224271: Completed study, sponsored by Mayo Clinic.
NCT05224271 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05224271 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
This study explores the use of the Hugo platform to involve study participants in their healthcare and treatments. The Hugo platform may allow researchers to collect better and more accurate real-time health data, from other clinics/hospitals, pharmacies and other electronic devices. The purpose of this research is to see if the use of the Hugo platform is consistent, accurate, cost effective, and time efficient, as it collects and transmits important real-time health information from other clinics/hospitals, pharmacies, and other electronic devices.
Primary Outcome
The difference in rates will be estimated. A chi square, or Fisher's exact test as appropriate, will be used to compare the rates between cohorts. A logistic regression model will be used to understand the association of patient and disease variables with the odds of completion (at least one of the surveys at the treated site).
Interventions
- OTHER Survey Administration
- OTHER Medical Device Usage and Evaluation
- OTHER Electronic Health Record Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2022-03-02 |
| Est. Completion | 2023-04-10 |
What the finished NCT05224271 record still lists
NCT05224271 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Survey Administration is the first listed.
NCT05224271 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05224271 about?
NCT05224271 is a clinical study titled "Evaluating Patient Reported Outcomes in Radiation Therapy, the PRO-RT Study". This study explores the use of the Hugo platform to involve study participants in their healthcare and treatments. The Hugo platform may allow researchers to collect better and more accurate real-time health data, from other clinics/hospitals, pharmacies and other electronic devices. The purpose of ...
What is the current status of trial NCT05224271?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2022-03-02. Estimated completion is 2023-04-10.
What interventions are being tested in trial NCT05224271?
The interventions under investigation include: Survey Administration (OTHER), Medical Device Usage and Evaluation (OTHER), Electronic Health Record Review (OTHER).
Who is sponsoring clinical trial NCT05224271?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI